Literature DB >> 7759388

Flucytosine--what is its future?

M A Viviani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7759388     DOI： 10.1093/jac/35.2.241

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

Review 1.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

2.  In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model.

Authors:  D Andes; M van Ogtrop
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 3.  The therapeutic monitoring of antimicrobial agents.

Authors:  E J Begg; M L Barclay; C J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 4.  Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy.

Authors:  Gina Wall; Jose L Lopez-Ribot
Journal:  Antibiotics (Basel)       Date:  2020-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.